Results 11 to 20 of about 53,966 (218)
Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal ...
Gondo M, Sakai T, Tsuneoka H, Kanehira C
doaj +2 more sources
Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, Comer GM
doaj +2 more sources
We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge,
Aditya Kelkar +6 more
doaj +2 more sources
Case of endophthalmitis following intravitreal injections of bevacizumab
Shinya Komori1, Akira Sawada1, Tsutomu Oguni1, Kiyofumi Mochizuki1, Kiyofumi Ohkusu21Department of Ophthalmology, 2Department of Microbiology, Gifu University Graduate School of Medicine, Gifu, JapanPurpose: We report a case of infectious endophthalmitis
Shinya Komori +3 more
doaj +1 more source
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
Mehmet Demir, Ersin Oba, Gökhan Gulkilik, Mahmut Odabasi, Erhan OzdalSisli Etfal Training and Research Hospital, Eye Clinic, Sisli, Istanbul, TurkeyPurpose: To present the functional and anatomic changes after intravitreal bevacizumab in eyes ...
Demir M +4 more
doaj +1 more source
Eleni Loukianou, Dimitrios Brouzas, Eleni Georgopoulou, Chrysanthi Koutsandrea, Michael ApostolopoulosEye Department, University of Athens, Athens, GreecePurpose: To evaluate the safety and efficacy of intravitreal injections of bevacizumab (Avastin& ...
Eleni Loukianou +3 more
doaj +1 more source
Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP)
Marey HM, Ellakwa AF
doaj +1 more source
Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study. [PDF]
ABSTRACT Background and Aims This study was designed to evaluate the safety, efficacy, and durability of suprachoroidal triamcinolone acetonide, administered either alone or in combination with intravitreal bevacizumab (IVB), in the treatment of diabetic macular edema (DME). Methods This prospective comparative interventional study was conducted in the
Ghaffar MT +6 more
europepmc +2 more sources
Intravitreal bevacizumab for vitreous hemorrhage [PDF]
Abstract Purpose Vitreous hemorrage is one of the major complications of ischemic retinopathies such as diabetic retinopathy. Our purpose was to describe the clinical outcome of patients who underwent a less invasive intervention than vitrectomy for therapy of persisting vitreous hemorrage Methods Our clinical interventional case series study included ...
Jost B, Jonas +3 more
openaire +2 more sources
Intravitreal Bevacizumab for Neovascular Glaucoma [PDF]
Purpose: To report 6-month and 1 year outcomes of eyes treated for neovascular glaucoma (NVG) with intravitreal bevacizumab injection and panretinal laser (PRP) compared to those receiving PRP alone. Design: retrospective, consecutive ...
Deepta, Vasudev +4 more
openaire +4 more sources

